About Company
- Legal Name: Nanjing Cellnuo Biopharmaceutical Co., Ltd.
- International Name: 南京赛尔诺生物医药有限公司 (Nanjing Cellnuo Biopharmaceutical Co., Ltd.), Nanjing, Jiangsu, China
- Brand / Trade Name: Cellnuo
- Registered country: China
- Address: Jiangsu
Description:
Nanjing Cellnuo Biopharmaceutical Co., Ltd., established in 2020, manufactures prophylactic biological products, enzymes, proteins/antigens/polypeptides, animal extracts, and specialized reagents, alongside drug development technology services. The company emphasizes customized service with flexible product quality, packaging, and payment arrangements, and — backed by international approvals, an experienced R&D staff, and a large product line — offers CMO contract manufacturing while accommodating buyer specifications and small orders, distributing across Central/South America, Eastern Europe, Asia, the Middle East, Western Europe, Australasia, Africa, and North America.
Business Activities
Active Pharmaceutical Ingredients (APIs)
API Manufacturer
Biopharmaceutical Services
CDMO / CMO
Biopharmaceutical Products
Biotech / Biopharmaceutical CompanyManufacturer
Natural Extracts & Herbal Ingredients
Manufacturer
Sales Markets
- Eastern Europe: Belarus, Bulgaria, Czech Republic, Hungary, Moldova, Poland, Romania, Slovakia
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Key Products/Services
- Active Pharmaceutical Ingredients (APIs): Recombinant Trypsin, Aprotinin, Carboxypeptidase B, KEX2 enzyme, Totipotent nuclease
- Contract & Outsourcing Services: CDMO Services
- Laboratory Chemicals, Solvents & Reference Standards: Liraglutide, Tirzepatide, Semaglutide, Retatrutide
- Natural Extracts & Herbal Ingredients: PDRN
- Biological & Fermentation Ingredients: GMP Peptide Manufacturing
- Biopharmaceutical Products: Insulin Glargine, Insulin Icodec, Orforglipron, Cagrilintide, Transferrin, insulin and analogue, Insulin Degludec, Recombinant Protein A, Recombinant Type III collagen
- Contract Research Organisations Services (CROs): Process Development
- Biopharmaceutical Services: bFGF, EGF, LR3 IGF-1
Our Products & Services
Sell · Biopharmaceutical Services
Sell · Biopharmaceutical Services
Sell · Biopharmaceutical Services
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Laboratory Chemicals, Solvents & Reference Standards
Sell · Natural Extracts & Herbal Ingredients
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Laboratory Chemicals, Solvents & Reference Standards
Sell · Laboratory Chemicals, Solvents & Reference Standards
Sell · Laboratory Chemicals, Solvents & Reference Standards
Sell · Active Pharmaceutical Ingredients (APIs)
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment